GGrantIndex
← Search

CLINICAL TRIAL: A PHASE II/III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIA

$18,333M01FY2008RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →